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GABA synapses play a critical role in many aspects of
circuit development and function. For example, con-
ditions that perturb GABA transmission have been
implicated in epilepsy. To identify genes that regulate
GABA transmission, we performed an RNAi screen
for genes whose inactivation increases the activity
of C. elegans body muscles, which receive direct in-
put from GABAergic motor neurons. We identified
90 genes, 21 of which were previously implicated in
seizure syndromes, suggesting that this screen has
effectively identified candidate genes for epilepsy.
Electrophysiological recordings and imaging of excit-
atory and inhibitory synapses indicate that several
genes alter muscle activity by selectively regulating
GABA transmission. In particular, we identify two
humoral pathways and several protein kinases that
modulate GABA transmission but have little effect
on excitatory transmission at cholinergic neuromus-
cular junctions. Our data suggest these conserved
genes are components of signaling pathways that
regulate GABA transmission and consequently may
play a role in epilepsy and other cognitive or psychiat-
ric disorders.
INTRODUCTION
Inhibitory synapses play a critical role in the proper development
and function of neuronal circuits. Fast synaptic inhibition in the
brain is primarily mediated by GABA. During development,
GABA transmission is required for ocular dominance plasticity
(Fagiolini and Hensch, 2000) and for refinement of receptive
fields in the visual system (Tao and Poo, 2005). Finally, condi-
tions that perturb GABA transmission have been implicated in
epilepsy and other cognitive disorders (Prosser et al., 2001;346 Neuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc.Schuler et al., 2001; Snodgrass, 1992). Consequently, identifying
genes that specifically regulate GABA transmission may reveal
important insights into function and development of circuits as
well as the contribution of circuit dysfunction to diseases of the
nervous system.
Systematic RNAi screens in cultured cell lines have allowed
extensive progress in identifying molecular components for var-
ious cellular processes (Perrimon and Mathey-Prevot, 2007). In
the model organisms C. elegans and Drosophila, it has become
possible to do RNAi screens on intact animals (Dietzl et al., 2007;
Fraser et al., 2000; Kamath et al., 2003). A prior systematic RNAi
screen focused on identifying genes in C. elegans that are re-
quired for synaptic function (Sieburth et al., 2005). It has been
proposed that the next logical step is to apply similar systematic
in vivo RNAi screens to the study of systems level problems such
as the regulation of behavioral circuits (Bargmann, 2005).
To identify genes that regulate GABA transmission, we de-
signedanRNAiscreenusingC.elegansbodymusclesasamodel.
Body muscles receive both excitatory (acetylcholine, ACh) and
inhibitory (GABA) inputs. The activity of body muscles can be
indirectly measured using the acetylcholinesterase inhibitor
aldicarb. Aldicarb treatment causes accumulation of ACh at neu-
romuscular junctions (NMJs), leading to acute paralysis. Hyper-
sensitivity to aldicarb-induced paralysis is caused by mutations
that increase ACh secretion (Gracheva et al., 2006; McEwen
et al., 2006) or that decrease inhibitory GABA input (Loria et al.,
2004). As described below, our screen identified several con-
served signaling pathways, including several that specifically
regulate GABA transmission.
RESULTS
An RNAi Screen for Increased Muscle Activity
Initial experiments using the acetylcholinesterase inhibitor aldi-
carb showed it could be used to identify genes that regulate
GABA transmission. For example, mutants lacking genes re-
quired for GABA transmission (e.g., unc-25 glutamic acid decar-
boxylase [GAD], unc-47 vesicular GABA transporter [VGAT], and
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Genes Regulating GABA SynapsesFigure 1. Screen for Aldicarb Hypersensi-
tivity
(A) Time course of paralysis for unc-25GAD versus
wild-type on 1 mM aldicarb (n = 9 and 6 trials, re-
spectively, 20–25 worms per trial). Future assays
and RNAi screen were scored at the 40 or 60 min
time point to determine hypersensitivity. Error
bars indicate SEM.
(B) Responsiveness of GABA mutants to aldicarb
and levamisole. Percent paralyzed unc-25 GAD,
unc-47 VGAT, and unc-49 GABAA animals at
60 min on 1 mM aldicarb (n = 12, 16, 6, and 6 trials
for wild-type, unc-25, unc-47, and unc-49, re-
spectively; 20–25 animals per trial) and 200 mM
levamisole (n = 5 trials for each genotype). GABA
transmission mutants are hypersensitive to both
drugs compared to wild-type (p < 0.0001). Error
bars indicate SEM.
(C) Schematic of screen protocol. Embryos from
an enhanced RNAi strain (eri-1;lin-15b) were
placed in wells containing bacteria expressing
dsRNA, and adults were scored for hypersensitiv-
ity to aldicarb 3 days later.
(D) Histogram of results from primary RNAi screen.
All clones were tested four times, and clones that
were scored as hypersensitive at least two out of
four times were retested four additional times
(black), while clones that scored hypersensitive
less than two times were not rescreened (white).
Clones that were scored as hypersensitive five
out of eight times or more were significantly differ-
ent from empty vector controls (p < 0.01 Fisher’s
exact test, 129 clones).
(E) Secondary screening by 2-Gen RNAi. The F1
generation of worms exposed to the 129 RNAi
clones from the primary screen were tested (in
quadruplicate) for hypersensitivity to aldicarb
(second generation, 2-Gen, RNAi). Negative log
p value is plotted against percent paralyzed.
Forty-nine clones were hypersensitive to aldicarb
following 2-Gen RNAi (p < 0.01 c2 test versus
empty vector controls, threshold indicated). Posi-
tive controls eat-16 RGS (filled triangle) and goa-1
Ga0 (filled square) are indicated.
(F) Aldicarb sensitivity of available loss-of-function
mutants for genes identified as hypersensitive to
aldicarb by 2-Gen RNAi. Twelve out of fourteen
(86%) of the mutants tested confirmed the aldi-
carb hypersensitivity phenotype. Grey bars = hy-
persensitivity (p < 0.01, t test); open bars indicate
wild-type sensitivity; error bars indicate SEM.unc-49 GABAAR) were hypersensitive to paralysis induced by
aldicarb and by a cholinergic agonist (levamisole) (Jiang et al.,
2005; Loria et al., 2004; Figures 1A and 1B). These results are
consistent with the idea that GABA mutants have increased
muscle activity and suggest that genes regulating GABA trans-
mission should be identified in a screen for hypersensitivity to
aldicarb-induced paralysis.
We screened an enhancedRNAi strain, which allows detection
of neuronal defects (Wang et al., 2005), for hypersensitivity to
aldicarb (Figure 1C). Two thousand seventy-two genes were se-
lected for this screen, based on the presence of domains that
predict involvement in signal transduction, synaptic localization,
cytoskeletal regulation, or membrane trafficking (Sieburth et al.,2005) and on their availability as clones in the C. elegans RNAi
feeding library (Kamath et al., 2003). In this primary screen,
RNAi treatment was initiated after embryonic and early larval
development was completed. One hundred twenty-nine genes
were identified whose inactivation caused aldicarb hypersensi-
tivity in significantly more replicates than did the empty vector
control (p < 0.01, Fisher’s exact test; Figure 1D).
To validate the results of the primary screen, we subjected the
positive genes to several secondary assays. First, all positive
genes were rescreened using two-generation RNAi treatments
(2-Gen RNAi), which typically result in stronger and more consis-
tent phenotypes. By 2-Gen RNAi, we confirmed that inactivation
of 49 genes caused significant (p < 0.01, c2 test) aldicarbNeuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc. 347
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Genes Regulating GABA Synapseshypersensitivity compared to empty vector controls (Figure 1E;
see Table S1 available online). For some positive genes, 2-Gen
RNAi treatments were not possible due to lethality, sterility, or
growth defects. For these genes, we repeated 1-Gen RNAi, con-
firming that inactivation of 30 genes caused significant (p < 0.01,
c2 test) aldicarb hypersensitivity (Table S1).
To further confirm the positive gene list, we tested whether
inactivation of these genes caused aldicarb hypersensitivity
across a range of experimental conditions. We used a panel
of mutants and drug treatments that cause aldicarb resistance
and tested whether 2-Gen RNAi of each gene could still pro-
duce significant aldicarb hypersensitivity (Figure 2). We also
tested whether inactivation of each gene increased muscle
responsiveness to the nicotinic agonist levamisole as an indi-
cation of increased muscle sensitivity or excitability. These re-
sults demonstrate that many of these genes regulate aldicarb
responses across a wide range of experimental conditions
(Figure 2).
Finally, we confirmed RNAi results by analyzing the effect of
loss-of-function mutations in positive genes. For the 2-Gen
RNAi positive genes, 12/14 (86%) available loss-of-function
alleles caused aldicarb hypersensitivity (p < 0.01, c2 test; Fig-
ure 1F; Table S1). Based on their annotated functions, a small
number of genes not screened by RNAi were also tested for al-
dicarb hypersentivity using available loss-of-function alleles. In
this manner, eleven additional positive genes were identified (Ta-
ble S1). Taken together, these secondary assays defined a set of
90 positive genes (Table S1). Fifty-six percent (51) of the positive
genes had mouse or human orthologs (Table S1). Twenty-one
positive genes had been previously implicated in GABA trans-
mission or seizure syndromes (Table 1). These results provide
confidence that our screen has effectively identified conserved
genes whose inactivation increases the activity of neuronal
circuits, including several that regulate GABA transmission.
Assaying ACh and GABA NMJs
Increased muscle activity could result from changes in either ex-
citatory or inhibitory synaptic transmission. We performed a vari-
ety of experiments to distinguish between these possibilities. To
maximize the severity of the observed defects, this analysis was
restricted to the subset of positive genes for which viable loss-of-
function mutants were available. To determine if genes altered
motor neuron development, we examined the morphology of
the GABA and cholinergic motor neurons. To assay synaptic
transmission at NMJs, we recorded endogenous excitatory
and inhibitory postsynaptic currents (EPSCs and IPSCs, respec-
tively) in body muscles.
We expect that some synaptic defects may not be detected in
these recordings, since the dissected preparation may not pre-
cisely mirror synaptic transmission in the intact animal. To assay
synaptic function in intact animals, we utilized aGFP-tagged syn-
aptic vesicle protein (SNB-1/Synaptobrevin) as a probe to detect
changes in presynaptic morphology and function. Expression of
GFP-tagged SNB-1 in motor neurons creates a continuous
pattern of fluorescent puncta in the nerve cords, where each
punctum corresponds to a single NMJ (Jin et al., 1999).
Changes in the distribution of GFP::SNB-1 have been used to
infer changes in the development or functional status of nerve348 Neuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc.terminals. The density of SNB-1 puncta is a measure of synaptic
density. The fluorescence intensity of SNB-1 puncta correlates
with the number of synaptic vesicles (SVs) at a synapse (as de-
termined by ultrastructural studies; Richmond et al., 1999;
Weimer et al., 2003). By contrast, the intensity of the diffuse
SNB-1 axon fluorescence (i.e., between puncta) correlates with
the abundance of Synaptobrevin in the plasma membrane (Ditt-
man and Kaplan, 2006), which is a steady-state measure of the
ratio of the rates of SV exocytosis and endocytosis (Fernan-
dez-Alfonso and Ryan, 2004). For example, the exocytosis defi-
cient mutants unc-13 Munc13 and unc-18 Munc18 have an
increased number of SVs at synapses (Richmond et al., 1999;
Weimer et al., 2003), increased SNB-1 punctal fluorescence
(Sieburth et al., 2005) and decreased SNB-1 axon fluorescence
(Dittman and Kaplan, 2006). The converse changes in SV num-
bers and SNB-1 fluorescence are found in the endocytosis defi-
cient mutants unc-57 Endophilin and unc-11 AP180 (Alfonso
et al., 1993; Dittman and Kaplan, 2006; Schuske et al., 2003; Sie-
burth et al., 2005). By combining the electrophysiological and
imaging approaches, we should maximize our ability to detect
synaptic defects.
Since we analyze both cholinergic and GABAergic synapses,
our experiments are internally controlled for several potential
outcomes. For example, gene inactivations that perturb the
health or development of the muscle cells should produce
equivalent defects in EPSCs and IPSCs and would likely pro-
duce morphological changes detected by imaging synaptic
markers. Furthermore, the excitatory input to GABAergic motor
neurons is provided exclusively by ACh released at cholinergic
NMJs (White et al., 1986); consequently, gene inactivations
that decrease excitatory drive should produce approximately
equivalent changes in the EPSC and IPSC rates. To increase
our chances of finding regulatory pathways, we focused our
analysis on genes that differentially regulate excitatory and in-
hibitory transmission. Using these assays, we identified several
genes that alter different aspects of ACh and GABA synapses
(Table 1).
Categorizing Genes Identified in the Screen
The objective of the screen was to identify genes that regulate
GABA synaptic transmission. Nevertheless, genes identified in
our screen could alter muscle activity by several mechanisms.
In particular, we expected to find three general categories of
genes. First, general presynaptic factors would be expected to
be recovered in our screen if their inactivation produces dispro-
portionately stronger defects in GABA transmission, thereby re-
sulting in a net increase in excitation. An example of this is pro-
vided by the rpm-1 gene, which encodes a large perisynaptic
E3 ubiquitin ligase (Schaefer et al., 2000; Zhen et al., 2000).
Mutants lacking RPM-1 have defects in both cholinergic and
GABAergic synapses; however, the GABA defects are more
severe (Nakata et al., 2005). Thus, rpm-1 is predicted to increase
muscle activity, and was recovered in our screen (Table S1).
Second, genes required for the proper development of
GABAergic neurons should be isolated in our screen. Prior to
our screen, only the unc-30 gene (which encodes a goosecoid
homeodomain protein) had been shown to specifically regulate
differentiation of GABA motor neurons (Jin et al., 1994). In our
Neuron
Genes Regulating GABA SynapsesFigure 2. Patterns of Aldicarb Responses of Following Inactivation of Positive Genes
Columns represent different genetic backgrounds or drug treatments. Here, we illustrate patterns for 25 clones whose inactivations cause hypersensitivity to
the cholinergic agonist levamisole (A) and 22 clones whose inactivations did not alter levamisole responses (B). The average percentage of animals paralyzed
in each condition is indicated by the shading. Scores not meeting the threshold for significance (p < 0.01, c2 test) were set to zero. These patterns of drug
sensitivity were clustered using eight different algorithms. Robust clusters, which remain together under at least six algorithms, are indicated by colored
bars. Four RNAi clones were included in analysis based on their mutant aldicarb phenotype (*) and npr-1 was clustered with levamisole hypersensitive genes
based on mutant data ( j).Neuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc. 349
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Genes Regulating GABA SynapsesTable 1. Pathways Implicated in GABA Transmission or Seizure Syndromes
Gene Locus Description
Human Hom/
Orth
Expression GABA
Imaging
Defect
Ephys.
Defect* Seizure-Related Phenotypes
Motor
Neuron
Body
Muscle
GABA-Related
Y37D8A.23 unc-25 GAD O Yes (GABA)1 No Inc. seizure susceptibility17
T21C12.1 unc-49 GABAAR H No Yes2 Inc. seizure susceptibility17
T20G5.6 unc-47 VGAT O Yes (GABA)3 No Inc. seizure susceptibility17
Presynaptic GPCR Pathways
C26C6.2 goa-1 Gao subunit O Yes (ACh, GABA)
4 No Yes E
C16C2.2 eat-16 RGS H Yes (ACh, GABA)5 No Regulated by seizure activity18,19
ZK180.1 gbb-2 mGABAR H Inc. seizure susceptibility20,21
F47D12.1 gar-2 mAChR H Yes (ACh, GABA)6 No Seizure resistance22
Wnt Signaling
C54D1.6 bar-1 b-catenin H Yes7 No Yes Inc. seizure susceptibility23
W10C8.2 pop-1 TCF O Yes8 No Yes
W01B6.1 cwn-2 Wnt O
W06F12.1 lit-1 Nemo-like S/T Kinase O
Endocrine Regulators
C39E6.6 npr-1 NPY-like R H Yes (GABA)9 No No I Inc. seizure susceptibility24–26
F33C8.1 tag-53 Attractin/Mahogany O Hypomyelination, tremors27–29
C11H1.3 Mahoganoid O Yes10 Yes10 Hypomyelination30
Y54E2A.1 GPCR/Galanin R H Inc. seizure susceptibility31,32
TGFb Pathway
T25F10.2 dbl-1 TGFb O Yes (ACh)11 No Yes I Inc. Kainate-induced excitoxicity33–35
R12B2.1 sma-4 Co-SMAD O No8 No8 TGFb signaling induced by Kainate36
R13F6.9 sma-3 R-SMAD O No12 No12 TGFb signaling induced by Kainate36
Kinase Pathways
K11E8.1 unc-43 CAMKII O Yes13 No Yes I Inc. seizure susceptibility37
R03G5.2 sek-1 MAPKK O #14 No Yes I Induced by Kainate38
F59A6.1 nsy-1 ASK1/MAPKKK O #15 No Induced by Kainate39
B0478.1 jnk-1 JNK/MAPK O Yes (ACh, GABA)16 No Resistant to Kainate-induced
excitotoxicity and seizure40
Other Seizure-Implicated
T26A5.9 dlc-1 dynein O Yes10 No Worm seizure model41
C17H12.1 dli-1 dynein intermed. chain O Worm seizure model41
Human orthology (O) was determined based on reciprocal best BLAST hits; homologs (H) have e-value <1e6.
Published expression patterns in motor neurons indicated as GABA and/or ACh where known. # neuronal expression described but ventral cord
expression not analyzed.
GABA imaging defects: yes for a change in GABAergic SNB-1 localization where p < 0.01 and/or a change in soluble GFP.
Ephys. defects*: newly described electrophysiology in this paper, I or E for changes in IPSC or EPSC recordings where p < 0.05.
Seizure-related phenotypes: in response to loss of function. Induction or regulation indicates gene responses in wild-type.
1McIntire et al. (1993); 2Bamber et al. (1999); 3Eastman et al. (1999); 4Se´galat et al. (1995); 5Hajdu-Cronin et al. (1999); 6Lee et al. (2000); 7Natarajan et al.
(2004); 8Reece-Hoyes et al. (2007); 9de Bono and Bargmann (1998); 10Hunt-Newbury et al. (2007); 11Morita et al. (1999); 12Wang et al. (2002); 13Reiner
et al. (1999); 14Tanaka-Hino et al. (2002); 15Sagasti et al. (2001); 16Kawasaki et al. (1999); 17Snodgrass (1992); 18Gold et al. (1997); 19Ingi et al. (1998);
20Prosser et al. (2001); 21Schuler et al. (2001); 22Hamilton et al. (1997); 23Campos et al. (2004); 24El Bahh et al. (2005); 25Noe et al. (2007); 26Vezzani et al.
(1999); 27Bronson et al. (2001); 28Gunn et al. (2001); 29Kuramoto et al. (2001); 30He et al. (2003); 31Mazarati et al. (2000); 32Mazarati et al. (1998);
33Brionne et al. (2003); 34Mesples et al. (2005); 35Tesseur et al. (2006); 36Luo et al. (2006); 37Butler et al. (1995); 38Jeon et al. (2000); 39Shinoda et al.
(2003); 40Yang et al. (1997); 41Williams et al. (2004).screen, we isolated several genes encoding components of the
canonical Wnt signaling pathway (Figure 3A; Table 1). We subse-
quently showed that some of these Wnt signaling genes are
required for outgrowth of GABA axons. In wild-type animals,350 Neuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc.the GABAergic D type motor neurons extend axons that form
a contiguous pattern filling the dorsal and ventral nerve cords.
In bar-1 mutants (which lack a b-catenin) and pop-1 mutants
(which lack the TCF transcription factor), there were prominent
Neuron
Genes Regulating GABA SynapsesFigure 3. Wnt Signaling Genes Regulate GABA Neuron Development
(A) The schematic shows the canonical Wnt signaling pathway. Boxes indicate genes identified in our screen or known by mutant phenotype to be aldicarb
hypersensitive.
(B) Confocal images of soluble GFP expression in GABAergic neurons of wild-type and bar-1 early larval stage 2 animals. White arrowheads indicate prominent
gaps in the dorsal cord where themain axonal processes posterior to theGABA neuron commissures normally occur (diagram). Asterisk indicates gaps present in
some wild-type animals between DD4 and DD5 at this developmental stage. These gaps are morphologically different from those seen in bar-1 animals in that
posterior axonal projections are developing normally from commissures.
(C) Quantification of posterior axon branching defects for wild-type, bar-1, and pop-1 in the GABAergic motor neurons (n = 58, 68, and 50) and wild-type and
bar-1 in the cholinergic neurons (n = 42 and 44).gaps in D neuron dorsal cord axons, visualized by expressing ei-
ther soluble GFP or SNB-1::GFP (Figures 3B and 3C and data not
shown). These gaps were apparently caused by incomplete ex-
tension of posteriorly-directed D neuron axons in the dorsal cord
and were most frequently observed in DD2 and DD4 axons. By
contrast, the morphology of cholinergic DA neuron axons in
the dorsal nerve cord was normal in bar-1 mutants (Figure 3C).
Thus, Wnt signaling mutants selectively disrupt GABA axon out-
growth, decreasing GABA transmission. These results are con-
sistent with recent studies showing that Wnt signaling regulates
other cell and axon migrations in C. elegans (Hilliard and Barg-
mann, 2006; Pan et al., 2006).
Third, we expected to identify genes encoding components of
a previously described G protein signaling network (Figure 4A;
Table 1). The heterotrimeric GTP-binding protein a subunits
GOA-1 Gao and EGL-30 Gaq have antagonistic effects on aldi-
carb responses, and these effects are thought to be mediated
by their antagonistic regulation of ACh secretion (Lackner et al.,
1999; Miller et al., 1999; Nurrish et al., 1999). Consistent with
this prediction, electrophysiological recordings indicated that
goa-1Gao mutants had an increased rate of endogenous EPSCs
(53%, p = 0.02), whereas the EPSC amplitudes were not signifi-
cantly different from wild-type controls (Figures 4B and 4C and
Figure S1A). The density of GFP::SNB-1 puncta in cholinergic
axons was not increased in goa-1 Gao mutants (Figures 4D and
4E). Therefore, the increased EPSC rate observed in goa-1 Gao
mutants was unlikely to be caused by increased synapse num-
bers. These results indicate that goa-1 Gao mutants have an
increased rate of ACh secretion, as previously proposed based
on genetic analysis of aldicarb responses.
The excitatory input to GABAergic motor neurons is provided
exclusively by ACh released at cholinergic NMJs (White et al.,1986). Consequently, we expected that the increased rate of
EPSCs observed in goa-1 mutants would be accompanied by
a corresponding increase in the IPSC rate. However, we found
that the rate and amplitude of endogenous IPSCs recorded
from goa-1 mutants were not significantly different from wild-
type controls (Figure 4C). This discrepancy may be explained
by a decrease in the density of GABAergic NMJs, since the
density of SNB-1::GFP puncta in GABAergic axons was slightly
decreased in goa-1 mutants (19%, p < 0.001) (Figure 4F).
While prior studies have identified many components of this
G protein signaling network, much less is known about the up-
stream G protein-coupled receptors (GPCRs) that impinge on
this network. Genes encoding several classes of GPCRs were
isolated in our screen (Figure 4A; Table 1), identifying additional
pathways that could modulate ACh release through this G pro-
tein signaling network.
Thus, the genes identified in our screen include 21 previously
implicated in seizure disorders, and include examples of each of
these three predicted classes of genes (Table 1). These results
suggest that our list is enriched for genes that influence muscle
activity by altering circuit properties, such as the relative balance
of excitatory and inhibitory inputs to the muscle. Beyond these
predicted classes of genes, we show that several genes identi-
fied in our screen modulate GABA transmission, thereby altering
muscle activity, as detailed below.
Endocrine Regulation of GABA Transmission
Several genes that encode components of endocrine regulatory
pathways were identified in our screen including TAG-53
Attractin, NPR-1 (related to the NPY receptor) (de Bono and
Bargmann, 1998), and Y54E2A.1 (a predicted Galanin receptor)
(Figure 5A; Table 1). Attractin is an auxiliary subunit of the AgoutiNeuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc. 351
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Genes Regulating GABA SynapsesFigure 4. G Protein Signaling Pathways
Regulate ACh Secretion
(A) The schematic shows the G protein signaling
networks that regulate synaptic vesicle exocytosis
at NMJs. Boxes indicate genes identified in our
screen or known to cause hypersensitivity to aldi-
carb when inactivated (Miller et al., 1999; Nurrish
et al., 1999). Mutants of components previously
shown to be resistant to aldicarb are shown in
dashed boxes (Lackner et al., 1999; Miller et al.,
1996).
(B) Representative traces of endogenous
EPSCs (top panel) and IPSCs (bottom panel)
recorded from adult wild-type (n = 29) and
goa-1 (n = 6) animals in 1 mM CaCl2 and 4 mM
MgCl2.
(C) Mean frequency (top panel) and amplitude
(bottom panel) of endogenous EPSCs (black
bars) and IPSCs (gray bars) for wild-type and
goa-1 animals. An asterisk indicates a significant
difference between wild-type and goa-1 animals
for EPSC frequency (53% increase, p = 0.02). Error
bars indicate SEM.
(D) Representative images of SNB-1::GFP ex-
pressed in the cholinergic motor neurons of wild-
type and goa-1 animals.
(E) Quantification of the number of SNB-1 puncta per unit length in cholinergic axons. n = 55 and 54 animals for goa-1 and wild-type, respectively.
(F) Quantification of SNB-1 puncta per unit length in GABAergic axons (n = 31 and 35 animals for goa-1 and wild-type.) A double asterisk indicates a significant
difference between wild-type and goa-1 for SNB-1 puncta density (19% decrease, p < 0.001.) Error bars indicate SEM.receptor (Haqq et al., 2003; He et al., 2001). A second compo-
nent of the Attractin signaling pathway, the E3 ubiquitin ligase
C11H1.3/Mahoganoid (He et al., 2003) was also identified in
our screen. We previously showed that inactivation of two genes
encoding insulin-like growth factors (ins-22 IGF and ins-31 IGF)
caused aldicarb-resistance (Sieburth et al., 2005). Thus, these
results identify endocrine pathways that antagonistically regu-
late aldicarb responsiveness, and presumably muscle activity.
Several results suggest that NPR-1 receptor effects onmuscle
activity are caused by changes in GABA transmission. Mutants
lacking NPR-1 receptors had a significantly reduced rate of
endogenous IPSCs (53%, p = 0.01), while IPSC amplitudes
were normal (Figures 5B and 5C and Figure S1B). The density
of SNB-1 puncta in the GABAergic axons was unaltered in
npr-1 mutants (p = 0.88) (Figures 5D and 5E), suggesting that
the decreased IPSC rate was not caused by a change in the
number of GABA synapses. SNB-1 axon fluorescence in
GABAergic neurons of npr-1 mutants was indistinguishable
from wild-type controls (p = 0.62; Figure 5F). Thus, although en-
dogenous IPSC rateswere decreased, we did not detect a corre-
sponding change in the distribution of SNB-1 (Figures 5D–5F).
Several factors could account for this discrepancy. For example,
if the rates of SV exocytosis and endocytosis were decreased
to the same extent, one would expect that IPSC rates would
decrease but the distribution of SNB-1 would be unaltered.
The decreased inhibition observed in npr-1 mutants cannot
be explained by a corresponding decrease in the excitatory drive
on the GABA motor neurons since the rate of endogenous
EPSCs was actually increased in npr-1 mutants (32%, p = 0.1),
although this effect was not significant (Figures 5B and 5C).
Similarly, there was no change in amplitude of endogenous
EPSCs nor in the density of SNB-1 puncta in the cholinergic352 Neuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc.axons (Figure 5G). Taken together, these results suggest that
npr-1 mutants have a selective reduction in the rate of GABA
transmission.
A TGFb Pathway Regulates GABA Transmission
Three genes encoding components of a TGFb signaling pathway
were identified in our screen (Figure 6A; Table 1). Inactivation of
dbl-1 TGFb, sma-4 co-SMAD, and sma-3 R-SMAD resulted in
hypersensitivity to aldicarb and levamisole, consistent with
increased muscle activity.
Mutants lacking DBL-1 had several defects in GABAergic
transmission. These mutants had a significantly decreased
IPSC rate (91%, p < 0.0001) compared to wild-type controls,
consistent with a decreased rate of GABA secretion in these
mutants (Figures 6B and S1C). The rate and amplitude of endog-
enous bodymuscle EPSCswere normal in dbl-1mutants lacking
(Figures 6B and 6C), as was the density of SNB-1 puncta in
cholinergic axons (Figure 6D). These results suggest that the
decreased inhibition observed in dbl-1mutants were not caused
by a corresponding decrease in the excitatory drive on the GABA
motor neurons. The density of GABAergic NMJs, as measured
by both presynaptic (SNB-1) and postsynaptic (UNC-49 GABAA)
puncta densities was actually slightly increased in dbl-1mutants
(12%, p = 0.005 and 13%, p < 0.0001), suggesting that the de-
creased IPSC rate was not caused by a decrease in the density
of the GABAergic NMJs (Figures 6E, 6F, and 6I). SNB-1 fluores-
cence in GABA axons was unaltered in dbl-1 mutants, suggest-
ing that the decreasedGABA secretion was not accompanied by
a change in the relative rates of SV exocytosis and endocytosis
(Figures 6E and 6G). These results indicate that dbl-1 mutants
have presynaptic defects leading to decreased GABA secretion.
Neuron
Genes Regulating GABA SynapsesFigure 5. Regulation GABA Transmission by npr-1/ Neuropeptide Y-like Receptor
(A) The schematic above summarizes neuropeptides that regulate energy homeostasis in mammals. Below, we summarize the effects of orthologous genes on
C. elegans aldicarb responses. Genes whose inactivation cause aldicarb hypersensitivity are indicated by the solid boxes while those causing resistance are
indicated by dashed boxes (Sieburth et al., 2005).
(B) Representative traces of endogenous EPSCs (top panel) and IPSCs (bottom panel) recorded from adult wild-type (n = 29) and npr-1 (n = 6) animals in 1 mM
CaCl2 and 4 mM MgCl2.
(C) Mean frequency (top panel) and amplitude (bottom panel) of endogenous EPSCs (black bars) and IPSCs (gray bars) for wild-type and npr-1 animals. An
asterisk indicates a significant difference between wild-type and npr-1 animals for IPSC frequency (53% decrease, p = 0.01). Error bars indicate SEM.
(D) Representative images of SNB-1::GFP expressed in the GABAergic motor neurons of wild-type and npr-1 animals.
(E and F) Quantification of the number of SNB-1 puncta per unit length (E) and the nonsynaptic, axonal SNB-1 fluorescence (F) in the GABAergic neurons. n = 31
and 28 animals for npr-1 and wild-type.
(G) Quantification of the number of SNB-1 puncta per unit length in the cholinergic axons. n = 31 and 25 animals for npr-1 and wild-type. Error bars indicate SEM.In addition to the decreased GABA secretion, several results
suggest that dbl-1 mutants also had postsynaptic defects at
GABAergic NMJs. IPSC amplitudes were significantly reduced
in dbl-1 mutants (40%, p < 0.01; Figure 6C). Changes in the
amplitude of postsynaptic currents can occur when muscle re-
sponsiveness to neurotransmitter is altered, or when the size
of presynaptic quanta is altered. To distinguish between these
possibilities, we recorded the muscle currents evoked by appli-
cation of the GABA agonist muscimol. The amplitude of musci-
mol-evoked currents were also significantly reduced in dbl-1
mutants (33%, p < 0.01), consistent with decreased muscle
sensitivity to GABA (Figure 6H).
We did several experiments to further characterize the mech-
anism for this change in muscle sensitivity. The abundance of
GFP-tagged UNC-49 GABAA subunits in the nerve cord was
not altered in dbl-1 mutants, suggesting that decreased GABA
sensitivity was not caused by decreased expression or targeting
of GABAA receptors (Figure 6I). Decreased muscle sensitivity
might be caused by expression of functionally impaired UNC-
49 GABAA receptors or by a structural change in GABAergic
NMJs leading to inefficient activation of GABAA receptors. To
test these possibilities, we analyzed the kinetics of endogenousIPSCs, which should provide a sensitive assay for both UNC-49
receptor function and for changes in the geometry of GABAergic
synapses. The shapes of the average endogenous IPSCs in
dbl-1 mutants and wild-type controls were indistinguishable,
suggesting that the kinetics of synaptic GABA responses were
not significantly altered in dbl-1 mutants (Fig. S2A). To more di-
rectly assess the structure of of GABAergic NMJs, we analyzed
the morphology of these synapses. We found that the alignment
of RAB-3 (RFP-tagged) and UNC-49 (GFP-tagged) at these syn-
apses was unaltered in dbl-1 mutants (Fig. S3). These results
suggest that DBL-1 regulates the function of UNC-49 receptors,
e.g., by regulating their insertion into the plasma membrane, or
their activation by GABA. Our results indicate that the increased
muscle activity observed in dbl-1 mutants was caused by both
pre and postsynaptic defects at GABAergic synapses.
Kinase Pathways Regulate GABA Transmission
Several genes encoding components of MAP kinase signaling
cascades were identified in our screen, including NSY-1 ASK1
(MAPKKK), SEK-1 (MAPKK), and JNK-1 (MAPK) (Figure 7A;
Table 1). In addition to the MAPK components, we found that in-
activation of another serine/threonine protein kinase, the type IINeuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc. 353
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Genes Regulating GABA SynapsesFigure 6. Regulation of GABA Transmission by a TGFb Pathway
(A) Schematic of a TGFb signaling pathway. Boxes indicate genes identified in our screen.
(B) Representative traces of endogenous EPSCs (top panel) and IPSCs (bottom panel) recorded from adult wild-type (n = 29) and dbl-1 (n = 6) animals in 1 mM
CaCl2 and 4 mM MgCl2.
(C) Mean frequency (top panel) and amplitude (bottom panel) of endogenous EPSCs (black bars) and IPSCs (gray bars) for wild-type and dbl-1 animals. A double
asterisk indicates a significant difference between wild-type and dbl-1 animals for IPSC frequency (91% decrease, p < 0.0001) and amplitude (40% decrease,
p < 0.01). Averaged endogenous IPSCs are shown above the respective bars for wild-type and dbl-1, scale bars are 5 pA and 5ms. Error bars indicate SEM.
(D) Quantification of the number of SNB-1 puncta per unit length in the cholinergic axons. n = 42 and 34 animals for dbl-1 and wild-type.
(E) Representative images of SNB-1::GFP expressed in the GABAergic motor neurons of wild-type and dbl-1 animals.
(F) Quantification of SNB-1 puncta per unit length in GABA axons (n = 51 and 42 animals for dbl-1 and wild-type). A double asterisk indicates a significant
difference between wild-type and dbl-1 for SNB-1 puncta density (12% increase, p = 0.005).
(G) Quantification of the nonsynaptic, axonal SNB-1 fluorescence in the GABAergic neurons. n = 51 and 42 animals for dbl-1 and wild-type.
(H) Muscimol-activated currents in wild-type and dbl-1 bodymuscles. TheGABA agonist Muscimol (100 mM)was pressure ejected onto bodymuscles for 0.5 s for
wild-type (n = 8) and dbl-1 (n = 6). Averaged responses for Muscimol-activated currents fromwild-type and dbl-1 are shown (left) and average peak responses are
quantified (right). An asterisk indicates a significant difference between wild-type and dbl-1 for Muscimol-activated current, (33% decrease, p < 0.01). Error bars
indicate SEM.
(I) Postsynaptic GABAAR::GFP imaging. Representative images of GABAAR::GFP in wild-type and dbl-1 animals (left panel) are accompanied by quantification of
the number of GABAAR post synaptic sites per unit length (left) and the abundance of GABAAR at synapses (right). A double asterisk indicates a significant
difference between wild-type and dbl-1 for GABAAR puncta density (13% increase, p < 0.0001). n = 30 for both dbl-1 and wild-type. Scale bar = 10mm. Error
bars indicate SEM.calcium- and calmodulin-dependent protein kinase (CaMKII)
UNC-43, also causes aldicarb hypersensitivity (Robatzek and
Thomas, 2000; Table S1). Thus, our results suggest that muscle
activity may be regulated by one or more protein kinase
cascades.354 Neuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc.Several results suggest that UNC-43 and SEK-1 regulate
GABA transmission. The rate of endogenous IPSCs was signifi-
cantly reduced in both unc-43 CaMKII (77%, p = 0.01) and sek-1
(47%, p = 0.04) mutants (Figures 7B and 7C and Figures S1F and
S1I). The rate and amplitude of endogenous EPSCs, and the
Neuron
Genes Regulating GABA Synapsesdensity of SNB-1 puncta in cholinergic axons were normal in
both unc-43 and sek-1 mutants (Figures 7B–7D, S1F, and S1I),
suggesting that the decreased inhibition was not caused by a
decrease in the excitatory input to the GABA motor neurons.
The density of SNB-1 puncta in GABA axons was unaltered in
these mutants, suggesting that the decreased GABA secretion
was not caused by a decrease in the number of GABA NMJs
(Figures 7E and 7F). SNB-1 fluorescence in GABA axons was
significantly decreased in both unc-43 CaMKII and sek-1 mu-
tants (18%, p < 0.001 and 26% p < 0.0001) (Figures 7E and
7G). Thus, GABA secretion was reduced in these mutants, as
assayed by both imaging and electrophysiological recordings.
Transgenes expressing UNC-43 in all neurons completely res-
cued the aldicarb hypersensitivity defect of unc-43 mutants,
while partial rescue was produced by expression in the GABA
motor neurons (Figure 7J). By contrast, UNC-43 expression in
cholinergic neurons or body muscles failed to rescue aldicarb
hypersensitivity (Figure 7J). Similarly, transgenes expressing
SEK-1 in GABA motor neurons partially rescued the aldicarb
hypersensitivity defect of sek-1 mutant Figure 7K). These data
suggest that UNC-43 and SEK-1 act in the D neurons to regulate
GABA secretion, although both are likely to act in additional
neurons as well.
We also observed evidence for a postsynaptic GABA defect in
unc-43 CaMKII mutants. The amplitude of endogenous IPSCs
and the amplitude of muscimol-evoked currents were both sig-
nificantly reduced in unc-43 CaMKII mutants (36%, p < 0.01,
and 44%, p < 0.05; Figures 7B, 7C, 7I, and S1G). Both were
normal in sek-1 mutants. The shapes of the average IPSCs in
unc-43 and wild-type controls were identical, suggesting that
UNC-43 CaMKII did not alter the kinetics of the synaptic GABAA
receptors nor the kinetics of synaptic GABA responses (Fig-
ure S2B). These results demonstrate that unc-43 CaMKII mutant
muscles are less responsive to GABA. The abundance of GFP-
tagged UNC-49 GABAA was significantly reduced in unc-43
CaMKII mutants (14%, p < 0.01), which could contribute to the
decreased GABA sensitivity (Figure 7J). These results suggest
that UNC-43 CaMKII and SEK-1MAPKK regulate inhibitory input
to the body muscles. These data are consistent with the finding
that CaMKII potentiates GABA whole-cell currents and IPSCs in
mammalian neurons (Kano et al., 1996; Wang et al., 1995).
Thus, in addition to its presynaptic role, CaMKII also plays a
conserved role in regulating the postsynaptic response to GABA.
DISCUSSION
An emerging area of interest in systems neuroscience is the im-
portance of balancing excitatory and inhibitory synaptic inputs
(E/I balance) in a circuit. Our results indicate that aldicarb respon-
siveness can be used as a systems-level assay for the balance of
excitatory and inhibitory input toC. elegans bodymuscles. Using
this assay, we identified 90 genes whose inactivation increased
muscle activity, including components of several phylogeneti-
cally conserved pathways. Although these genes were identified
as regulators of muscle activity, several results suggest that the
genes identified here may perform similar functions in the brain.
First, in mammals, GABA is utilized in the CNS and not at
NMJs; consequently, conserved genes regulating GABA synap-ses are likely to act in the brain. Second, 21of the identified genes
were previously implicated in GABA transmission or seizure
disorders in mammals, providing further evidence that these
genes have conserved functions regulating activity in the brain.
We identify four genes as modulators of GABA transmission.
These genes are components of conserved signaling pathways,
(TGFb, MAP kinase, and NPY signaling pathways), suggesting
these pathways may differentially regulate GABA transmission.
Mutations in these genes decreased GABA transmission but
did not reduce cholinergic transmission. While there has been
extensive analysis of pathways that modulate excitatory synap-
tic transmission, much less is known about regulation of inhibi-
tory transmission. Recent studies suggest that the adhesion
molecules Neuroligin-2 and Sema4D promote formation of
GABA synapses but not glutamatergic synapses in cultured ro-
dent neurons (Chih et al., 2005; Graf et al., 2006; Paradis et al.,
2007). Beyond these precedents, relatively little is known about
molecules that differentially impact the development or function
of inhibitory synapses. Below we briefly discuss the potential
implications our results have for the mechanisms regulating
inhibitory transmission and circuit activity.
Regulation of GABA Transmission by Conserved
Kinase Pathways
Several genes encoding components of MAP kinase signaling
cascades were identified in our screen, including NSY-1 ASK1
(MAPKKK), SEK-1 (MAPKK), and JNK-1 (MAPK) and the kinase
UNC-43 CAMKII. These kinases were previously implicated in
asymmetric expression of an odorant receptor (STR-2) and in in-
nate immune responses to bacterial pathogens (Sagasti et al.,
2001; Tanaka-Hino et al., 2002). Our results suggest that a similar
MAPK pathway regulates GABA transmission. Previous studies
showed that UNC-43/CAMKII is required for the normal activity
of enteric, egg-laying, defecation, and male copulatory muscles
(LeBoeuf et al., 2007; Reiner et al., 1999); however, the mecha-
nism underlying these effects has not been determined. A recent
study showed that mutants lacking UNC-43 have decreased
body muscle IPSC rates and amplitudes, which are consistent
with the results we report here (Liu et al., 2007). The function of
these kinases in regulating circuit activity may be conserved,
sincemouse knockouts lacking CaMKII are seizure prone (Butler
et al., 1995) and orthologous mouse MAPK components (ASK1/
MKK6/JNK) have been implicated in seizure induced neuronal
cell death (Brecht et al., 2005; Shinoda et al., 2003). We propose
that the corresponding pathways may also modulate inhibitory
neurotransmission in mammals.
Regulation of GABA Transmission by Conserved
Endocrine Regulators
We identify several endocrine pathway components (e.g., NPR-1/
NPY-R, Y54E2A.1/Galanin-R, Insulin-like growth factors, and
agouti pathway components) as potential regulators of muscle
activity. In particular, NPR-1 receptors regulate the rate of
GABA secretion by ventral cordmotor neurons. Previously, insu-
lin signaling pathways were implicated in diapause and longevity
(Kimura et al., 1997), while NPR-1/NPY-R signaling was impli-
cated in foraging behavior (de Bono and Bargmann, 1998). In
mammals, the orthologous genes regulate energy homeostasisNeuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc. 355
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Genes Regulating GABA SynapsesFigure 7. Regulation of GABA Transmission by Kinase Pathways
(A) Schematic of aMAP kinase signaling pathway. On the right, we list several genes encoding components of MAP kinase signaling cascades that were identified
in our screen (boxed).
(B) Representative traces of endogenous EPSCs (left panel) and IPSCs (right panel) recorded from adult wild-type (n = 29), unc-43 (n = 6), and sek-1 (n = 6) animals
in 1 mM CaCl2 and 4 mM MgCl2.
(C) Mean frequency (top panel) and amplitude (bottom panel) of endogenous EPSCs (black bars) and IPSCs (gray bars) for wild-type, unc-43, and sek-1 animals.
Averaged endogenous IPSCs are shown for wild-type, unc-43, and sek-1 above the respective IPSC amplitude bars. Scale bars are 5 pA and 5 ms. An asterisk
indicates a significant difference between wild-type and unc-43 (77% decrease, p = 0.01) or sek-1 (47% decrease, p = 0.04) animals for IPSC frequency, and
a double asterisk indicates a significant difference between wild-type and unc-43 for IPSC amplitude (36% decrease, p < 0.01).
(D) Quantification of the number of SNB-1 puncta per unit length in the cholinergic axons. n = 31, 28, and 34 animals for unc-43, sek-1, and wild-type.
(E) Representative images of SNB-1::GFP expressed in the GABAergic neurons of wild-type, unc-43, and sek-1 animals.
(F) Quantification of the number of SNB-1 puncta per unit length in these GABAergic neurons.
(G) Quantification of the nonsynaptic axonal SNB-1 fluorescence in these GABAergic neurons (gray bars). A double asterisk indicates a significant difference
between wild-type and unc-43 (18% decrease, p < 0.001) or sek-1 (26% decrease, p < 0.0001) for GABA neuron SNB-1 axonal fluorescence. n = 46, 44, and356 Neuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc.
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Genes Regulating GABA Synapsesand feeding behaviors. For example, feeding behavior and
consumption of energy stores is promoted by neuropeptide Y
(NPY) and the agouti related peptide, while insulin has the
converse effects (Saper et al., 2002). Our results suggest the
intriguing possibility that energy homeostasis pathways play
a conserved role in regulating inhibitory transmission, providing
a mechanism to couple metabolic status to changes in circuit
activity.
Several results from human and rodent studies demonstrate
that circuit activity and behavior are regulated by metabolic sta-
tus. First, a low-carbohydrate ketogenic diet effectively reduces
the incidence of seizures in patients with drug resistant forms of
epilepsy (Freeman et al., 1998; Thiele, 2003). Second, hypogly-
cemic shock, e.g., following insulin overdose, induces seizures
in humans and rodents (Kaplan and Fisher, 2005). Third, NPY
and Galanin knockout mice are seizure prone (Baraban et al.,
1997; Jacoby et al., 2002). Thus, we speculate that these path-
ways may be enriched for genes that regulate susceptibility to
epilepsy and perhaps other psychiatric disorders.
Regulation of GABA Transmission by a TGFb Pathway
We show that another secreted ligand, DBL-1 TGFb, also pro-
motes GABA transmission, being required for both a normal
IPSC rate and for normal muscle responsiveness to GABA.
DBL-1 TGFb is endogenously produced by the cholinergic motor
neurons (Suzuki et al., 1999). Thus, the activity of the cholinergic
neurons may enhance inhibitory input via changes in DBL-1
TGFb secretion. DBL-1 TGFb secretion also regulates body
size (Suzuki et al., 1999); therefore, this pathway coordinately
regulates the size and activity of muscle cells. Interestingly,
TGFb signaling was previously implicated in controlling develop-
mental growth of Drosophila NMJs, which are glutamatergic
(Aberle et al., 2002; Sweeney and Davis, 2002).
Implications for Regulating Circuit Activity
Our results suggest that muscle activity is tightly regulated in
C. elegans and that much of this regulation occurs at the circuit
level. The extensive control of activity could reflect several
aspects of C. elegans development and anatomy. First, it is pos-
sible that changes in the balance of excitation and inhibition are
required to compensate for the large increase in body size or
for changes in the motor circuit that occur during larval and
adult development, as has been reported for other invertebratemodel systems (Li et al., 2002; Lnenicka and Mellon, 1983; Zito
et al., 1999). In particular, it is noteworthy that at all stages of
development, there are roughly 3-fold more cholinergic motor
neurons than GABAergic motor neurons (embryo 16 cholinergic
and 6 GABAergic motor neurons; adult 56 cholinergic and 19
GABAergic). Given this disparity in cell numbers, it seems likely
that modulatory pathways are required to maintain appropriate
muscle activity. Excitatory input to the GABA motor neurons is
exclusively provided at cholinergic NMJs (White et al., 1986);
consequently, changes in synaptic drive would produce propor-
tionate changes in excitation and inhibition. Thus, to modulate
muscle activity by altering the balance of excitation and inhibi-
tion, it is necessary to invoke nonsynaptic signaling pathways
(e.g., the NPY and DBL-1 TGFb pathways identified here).
The intricate regulation of excitation and inhibition observed in
C. elegans is strikingly similar to that seen in mammals. In many
brain regions, excitatory and inhibitory conductances are held in
a constant ratio (Haider et al., 2006; Liu, 2004; Marder and Goail-
lard, 2006; Turrigiano, 2007). In cultured neurons, this balance
results from a constant ratio of excitatory and inhibitory synap-
ses along individual dendrites (Liu, 2004). Relatively little is
known about how this ratio is maintained. We speculate that
some of the genes identified here may play a role in this process.
Candidate Genes for Epilepsy and Other Psychiatric
Disorders
Many cognitive and affective disorders are thought to arise from
perturbations of E/I balance. Increased activity, resulting from
increased excitatory inputs or decreased inhibitory inputs, leads
to seizure activity, such as in epilepsy (McNamara et al., 2006).
Decreased inhibition has been implicated in schizophrenia
(Akbarian and Huang, 2006) and autism (Rubenstein and Merze-
nich, 2003). Conversely, excess inhibition has been proposed to
occur inmental retardation syndromes, such as Down’s and Rett
Syndromes (Dani et al., 2005; Kleschevnikov et al., 2004). Phar-
macological blockade of inhibition enhances long term potentia-
tion (LTP) and ameliorates learning defects in a mouse model for
Down’s Syndrome (Fernandez et al., 2007; Kleschevnikov et al.,
2004). Thus, identifying genes that regulate GABA synapses will
provide candidate genes for inherited forms of these disorders,
may provide new insights into the mechanisms underlying cog-
nitive and affective disorders, and may suggest potential treat-
ments for these disorders. For example, altered secretion of52 animals for unc-43, sek-1, and wild-type for GABA neuron quantification.
(H) Muscimol-activated currents in wild-type, unc-43, and sek-1 body muscles. The GABA agonist Muscimol (100 mM) was pressure ejected onto body muscles
for 0.5 s for wild-type (n = 8), unc-43 (n = 6), and sek-1 (n = 6). Averaged responses for Muscimol-activated currents from wild-type, unc-43, and sek-1 are shown
(left) and average peak responses are quantified (right). An asterisk indicates a significant difference between wild-type and unc-43 for Muscimol-activated
current, (44% decrease, p < 0.05). Error bars indicate SEM.
(I) Postsynaptic GABAAR::GFP imaging. Representative images of GABAAR::GFP in wild-type, unc-43, and sek-1 animals (left) are accompanied by quantification
of the abundance of GABAAR at synapses (right). A double asterisk indicates a significant difference between wild-type and unc-43 for GABAAR puncta fluores-
cence (14% decrease, p < 0.01). n = 30 for each genotype. Scale bar = 10mm. Error bars indicate SEM throughout figure.
(J) Aldicarb hypersensitivity of wild-type (n = 12 trials), unc-43(n = 15 trials), and unc-43 mutants carrying transgenes driving unc-43 expression in GABA motor
neurons (Punc-25::unc-43, n = 10 trials, 3 independent lines), muscle (Pmyo-3::unc-43 n = 6 trials, 3 independent lines), cholinergic neurons (Punc-17::unc-43
n = 4 trials, 2 independent lines), and all neurons (Psnb-1::unc-43 n = 6 trials, 3 independent lines). A double asterisk indicates a significant difference compared
to wild-type (p < 0.0001). A double dagger indicates a significant difference between unc-43 mutants and transgenic rescue (p < 0.0001).
(K) Aldicarb hypersensitivity of wild-type (n = 8 trials), sek-1 (n = 7 trials), and sek-1mutants carrying a transgene (Punc-30::sek-1, n = 13 trials, 4 independent lines)
driving expression in GABA motor neurons (GABA resc.). A double asterisk indicates a significant difference compared to wild-type (p < 0.01). A double dagger
indicates a significant difference betweens sek-1 and transgenic rescue (p < 0.01). Error bars indicate SEM throughout figure.Neuron 58, 346–361, May 8, 2008 ª2008 Elsevier Inc. 357
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Genes Regulating GABA Synapsesthe ligand for NPR-1 receptors or of DBL-1 would be expected to
alter the balance of excitation and inhibition, thereby altering cir-
cuit activity. Thus, manipulation of these pathways may provide
a useful therapeutic strategy for treating cognitive or psychiatric
disorders in which E/I balance has been disrupted.
EXPERIMENTAL PROCEDURES
A detailed description of all methods is included in the Supplemental Data.
C. elegans Strains
Strains were maintained at 20C. OP50 E. coli was used for feeding. The wild-
type reference strain was N2 Bristol.
RNAi Feeding Experiments and Screen
The 2072 genes selected for this screen were previously described (Sieburth
et al., 2005). RNAi feeding screens were performed as described (Kamath
and Ahringer, 2003; Kamath et al., 2003). Aldicarb assays were performed
on young adults as described (Lackner et al., 1999).
We used a panel of mutants that cause aldicarb resistance (each in an
eri-1;lin-15b background) and tested whether RNAi of each gene could still pro-
duce significant aldicarb hypersensitivity. Hierarchical clusteringwas performed
using Cluster 3.0 (Eisen et al., 1998). Clusters were initially identified using an
average variancemethodwith a Euclidianmeasure of distance and then robust-
ness was assessed as detailed in Supplemental Experimental Procedures.
Fluorescence Microscopy and Quantitative Analysis
All imaging experiments were done using a Zeiss Aviovert 100 microscope
equipped with an ORCA CCD camera (Hamamatsu). Animals were immobi-
lized with 30 mg/ml BDM (Sigma). Line scans of dorsal cord fluorescence
(for GFP::SNB-1) or punctal fluorescence intensity (to estimate the abundance
of synaptic GABAAR for UNC-49::GFP) were analyzed in Igor Pro (WaveMet-
rics) using custom-written software (Burbea et al., 2002), and all statistics
reported from imaging experiments are from Kolmogorov-Smirnov tests
(KS tests).
Electrophysiology
Electrophysiology was done on dissected C. elegans as previously described
(Richmond and Jorgensen, 1999). All recording conditions were as described
(Sieburth et al., 2007). Statistical significance was determined on a worm-
by-worm basis using the Mann-Whitney test for Muscimol puff experiments,
Student’s t test for comparison of mean frequency and amplitude for EPSCs
and IPSCs. The Kolmogorov-Smirnov test was used to determine statistical
significance for all cumulative probabilities.
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/58/3/346/DC1/.
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